nach oben

Clinical Rheumatology

Erschienen in:

31.07.2019 | Original Article

Sirt1 inhibits gouty arthritis via activating PPARγ

verfasst von: Juan Wang, Guangliang Chen, Liangjing Lu, Hejian Zou

Erschienen in: Clinical Rheumatology | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

Objective

To identify the effects of Sirtuin 1 (Sirt1) on gouty arthritis and investigate the underlying mechanisms.

Methods

A gouty arthritis model was established by intra-articular injection of monosodium urate (MSU, 1 mg) crystal solution into the left foot pad of C57BL/6 mice. After pretreating the gouty arthritis mice with intra-articular injection of Sirt1 agonist (Resveratrol, RSV, 20 mg/kg) or peroxisome proliferator-activated receptor γ (PPARγ) inhibitor (T0070907, 1 mg/kg), the degree of joint inflammation of the gouty arthritis mice was evaluated by clinical integration of joint inflammation and hematoxylin and eosin (H&E) staining. The mRNA expression of Sirt1 and PPARγ were determined by real-time polymerase chain reaction (PCR). The expression profiling of inflammatory cytokines and chemokines in mouse joint tissues were determined by multi-factor assay kits. Peritoneal macrophages were isolated from mice and tested the effects of RSV and/or PPARγ on pro-inflammatory cytokines secretion by PCR.

Results

Sirt1 agonist significantly suppressed the onset of gouty arthritis induced by MSU and reduced the infiltration of inflammatory cells in the joints. Sirt1 agonist significantly promoted the expression of PPARγ, while decreased the expression of interleukin (IL)-1β, IL-1α, IL-6, interferon-γ (IFN-γ), monocyte chemotactic protein 1(MCP-1), tumor necrosis factor a (TNF-α), and chemokines (CXCL-1, CXCL-5, CCL-22) induced by MSU in joint tissues. After blocking PPARγ with T0070907 or by siRNA, the anti-inflammatory effect of Sirt1 agonist on gouty arthritis disappeared and the expression of pro-inflammatory molecules were not significantly reduced.

Conclusions

Sirt1 may control the acute onset of gouty arthritis in mice by inhibiting the infiltration of inflammatory cells and the secretion of pro-inflammatory molecules through PPARγ.

Key Points

• Sirt1 and its activator, RSV, attenuate the severity of gouty arthritis in mice.

• Sirt1 inhibits the infiltration of inflammatory cells and the secretion of pro-inflammatory molecules in MSU-induced arthritis.

• Sirt1 inhibits inflammation partially dependent on PPARγ.

Schumacher HR (1996) Crystal-induced arthritis: an overview. Am J Med 100(2A):46S–52SCrossRef

Di Giovine FS, Malawista SE, Nuki G, Duff GW (1987) Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1. J Immunol 138(10):3213–3218PubMed

Guerne PA, Terkeltaub R, Zuraw B, Lotz M (1989) Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes. Arthritis Rheum 32(11):1443–1452CrossRef

Matsukawa A, Yoshimura T, Maeda T, Takahashi T, Ohkawara S, Yoshinaga M (1998) Analysis of the cytokine network among tumor necrosis factor alpha, interleukin-1beta, interleukin-8, and interleukin-1 receptor antagonist in monosodium urate crystal-induced rabbit arthritis. Lab Investig 78(5):559–569PubMed

di Giovine FS, Malawista SE, Thornton E, Duff GW (1991) Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution. J Clin Invest 87(4):1375–1381. https://doi.org/10.1172/JCI115142 CrossRefPubMedPubMedCentral

Wang J, Zhu XX, Liu L, Xue Y, Yang X, Zou HJ (2016) SIRT1 prevents hyperuricemia via the PGC-1alpha/PPARgamma-ABCG2 pathway. Endocrine 53(2):443–452. https://doi.org/10.1007/s12020-016-0896-7 CrossRefPubMed

Chen H, Zheng S, Wang Y, Zhu H, Liu Q, Xue Y, Qiu J, Zou H, Zhu X (2014) The effect of resveratrol on the recurrent attacks of gouty arthritis. Clin Rheumatol. https://doi.org/10.1007/s10067-014-2826-5

Borra MT, Smith BC, Denu JM (2005) Mechanism of human SIRT1 activation by resveratrol. J Biol Chem 280(17):17187–17195. https://doi.org/10.1074/jbc.M501250200 CrossRefPubMed

Knight JR, Milner J (2012) SIRT1, metabolism and cancer. Curr Opin Oncol 24(1):68–75. https://doi.org/10.1097/CCO.0b013e32834d813b CrossRefPubMed

10.

Pham J, Arul Nambi Rajan K, Li P, Parast MM (2018) The role of Sirtuin1-PPARgamma axis in placental development and function. J Mol Endocrinol 60(4):R201–R212. https://doi.org/10.1530/JME-17-0315 CrossRefPubMed

11.

Engler A, Tange C, Frank-Bertoncelj M, Gay RE, Gay S, Ospelt C (2016) Regulation and function of SIRT1 in rheumatoid arthritis synovial fibroblasts. J Mol Med (Berl) 94(2):173–182. https://doi.org/10.1007/s00109-015-1332-9 CrossRef

12.

Siebert A, Goren I, Pfeilschifter J, Frank S (2016) Anti-inflammatory effects of rosiglitazone in obesity-impaired wound healing depend on adipocyte differentiation. PLoS One 11(12):e0168562. https://doi.org/10.1371/journal.pone.0168562 CrossRefPubMedPubMedCentral

13.

Denko CW, Whitehouse MW (1976) Experimental inflammation induced by naturally occurring microcrystalline calcium salts. J Rheumatol 3(1):54–62PubMed

14.

Martin WJ, Walton M, Harper J (2009) Resident macrophages initiating and driving inflammation in a monosodium urate monohydrate crystal-induced murine peritoneal model of acute gout. Arthritis Rheum 60(1):281–289. https://doi.org/10.1002/art.24185 CrossRefPubMed

15.

Orlowsky EW, Stabler TV, Montell E, Verges J, Kraus VB (2014) Monosodium urate crystal induced macrophage inflammation is attenuated by chondroitin sulphate: pre-clinical model for gout prophylaxis? BMC Musculoskelet Disord 15:318. https://doi.org/10.1186/1471-2474-15-318 CrossRefPubMedPubMedCentral

16.

Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW (2004) Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23(12):2369–2380. https://doi.org/10.1038/sj.emboj.7600244 CrossRefPubMedPubMedCentral

17.

Kauppinen A, Suuronen T, Ojala J, Kaarniranta K, Salminen A (2013) Antagonistic crosstalk between NF-kappaB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal 25(10):1939–1948. https://doi.org/10.1016/j.cellsig.2013.06.007 CrossRefPubMed

18.

Akahoshi T, Namai R, Murakami Y, Watanabe M, Matsui T, Nishimura A, Kitasato H, Kameya T, Kondo H (2003) Rapid induction of peroxisome proliferator-activated receptor gamma expression in human monocytes by monosodium urate monohydrate crystals. Arthritis Rheum 48(1):231–239. https://doi.org/10.1002/art.10709 CrossRefPubMed

19.

Calleri E, Pochetti G, Dossou KSS, Laghezza A, Montanari R, Capelli D, Prada E, Loiodice F, Massolini G, Bernier M, Moaddel R (2014) Resveratrol and its metabolites bind to PPARs. Chembiochem 15(8):1154–1160. https://doi.org/10.1002/cbic.201300754 CrossRefPubMedPubMedCentral

20.

Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, Machado De Oliveira R, Leid M, McBurney MW, Guarente L (2004) Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429(6993):771–776. https://doi.org/10.1038/nature02583 CrossRefPubMedPubMedCentral

21.

Qiang L, Wang L, Kon N, Zhao W, Lee S, Zhang Y, Rosenbaum M, Zhao Y, Gu W, Farmer SR, Accili D (2012) Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Ppargamma. Cell 150(3):620–632. https://doi.org/10.1016/j.cell.2012.06.027 CrossRefPubMedPubMedCentral

22.

Han L, Zhou R, Niu J, McNutt MA, Wang P, Tong T (2010) SIRT1 is regulated by a PPAR{gamma}-SIRT1 negative feedback loop associated with senescence. Nucleic Acids Res 38(21):7458–7471. https://doi.org/10.1093/nar/gkq609 CrossRefPubMedPubMedCentral

23.

Lee MF, Liou TH, Wang W, Pan WH, Lee WJ, Hsu CT, Wu SF, Chen HH (2013) Gender, body mass index, and PPARgamma polymorphism are good indicators in hyperuricemia prediction for Han Chinese. Genet Test Mol Biomarkers 17(1):40–46. https://doi.org/10.1089/gtmb.2012.0231 CrossRefPubMedPubMedCentral

24.

Ruiz-Miyazawa KW, Staurengo-Ferrari L, Pinho-Ribeiro FA, Fattori V, Zaninelli TH, Badaro-Garcia S, Borghi SM, Andrade KC, Clemente-Napimoga JT, Alves-Filho JC, Cunha TM, Fraceto LF, Cunha FQ, Napimoga MH, Casagrande R, Verri WA Jr (2018) 15d-PGJ2-loaded nanocapsules ameliorate experimental gout arthritis by reducing pain and inflammation in a PPAR-gamma-sensitive manner in mice. Sci Rep 8(1):13979. https://doi.org/10.1038/s41598-018-32334-0 CrossRefPubMedPubMedCentral

25.

Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, Karin M, Santoro MG (2000) Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 403(6765):103–108. https://doi.org/10.1038/47520 CrossRefPubMed

26.

Straus DS, Pascual G, Li M, Welch JS, Ricote M, Hsiang CH, Sengchanthalangsy LL, Ghosh G, Glass CK (2000) 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc Natl Acad Sci U S A 97(9):4844–4849CrossRef

27.

Tani Y, Isobe Y, Imoto Y, Segi-Nishida E, Sugimoto Y, Arai H, Arita M (2014) Eosinophils control the resolution of inflammation and draining lymph node hypertrophy through the proresolving mediators and CXCL13 pathway in mice. FASEB J 28(9):4036–4043. https://doi.org/10.1096/fj.14-251132 CrossRefPubMedPubMedCentral

Titel: Sirt1 inhibits gouty arthritis via activating PPARγ
verfasst von: Juan Wang
Guangliang Chen
Liangjing Lu
Hejian Zou
Publikationsdatum: 31.07.2019
Verlag: Springer London
Erschienen in: Clinical Rheumatology / Ausgabe 11/2019
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-019-04697-w

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Objective

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2019

Association between three non-insulin-based indexes of insulin resistance and hyperuricemia

Evaluation of the relationship between osteoporosis, balance, fall risk, and audiological parameters

Less IgA deposits with more severe disease: the immunoclinical paradox in Henoch-Schönlein Purpura with MEFV mutations

The expression of GAS5, THRIL, and RMRP lncRNAs is increased in T cells of patients with rheumatoid arthritis

Mortality of patients with rheumatoid arthritis requiring intensive care: a single-center retrospective study